Why percutaneous revascularisation might not reduce the risk of myocardial infarction and mortality in patients with stable CAD?

Percutaneous coronary intervention (PCI) is widely adopted to treat chronic coronary artery disease. Numerous randomised trials have been conducted to test whether PCI may provide any prognostic advantage over oral medical therapy (OMT) alone, without definitive results. This has maintained the para...

Descripción completa

Detalles Bibliográficos
Autores principales: Benenati, Stefano, De Maria, Giovanni Luigi, Kotronias, Rafail, Porto, Italo, Banning, Adrian P
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Coronary Artery Disease
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619108/
https://www.ncbi.nlm.nih.gov/pubmed/37890892
http://dx.doi.org/10.1136/openhrt-2023-002343

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619108/
https://www.ncbi.nlm.nih.gov/pubmed/37890892
http://dx.doi.org/10.1136/openhrt-2023-002343

Ejemplares similares